Terminated PHASE1 INTERVENTIONAL 2-arm NCT00471692

Local Anaesthetic Following Hernia Repair

A Randomised, Double Blind, Placebo Controlled Study to Compare Ilio Inguinal Nerve Block and Local Wound Irrigation

Sponsor: Royal Hobart Hospital

Interventions Ropivicaine

Updated 5 times since 2017 Last updated: Oct 26, 2015 Started: Oct 31, 2006 Primary completion: Oct 31, 2009 Completion: Nov 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Due to high incidence of neurological complication in those with ilioinguinal block

Other terminated trials from Royal Hobart Hospital

Recurrence · Phase PHASE3 · Dec 2013

More terminations from Royal Hobart Hospital

Listed as NCT00471692, this PHASE1 trial focuses on Inguinal Hernias and remains terminated or withdrawn. Sponsored by Royal Hobart Hospital, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE1

First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Royal Hobart Hospital

Data source: Royal Hobart Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hobart, Australia